These studies suggest that regulation of α-tubulin acetylation plays a role in the pathogenic mechanisms underlying these neurodegenerative diseases and open the possibility of using HDAC6 inhibition as therapy for these diseases [266,358,364]. The gene discussed is HDAC6; the disease is neurodegenerative disease.